{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:09:45Z","timestamp":1786115385930,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"DOI":"10.1186\/s12931-026-03856-3","type":"journal-article","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:13:49Z","timestamp":1785982429000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Utility of mouse precision cut lung slices as an in vitro model for interrogating the lung immune response against bacterial pathogens in the context of immunomodulatory therapeutics"],"prefix":"10.1186","volume":"27","author":[{"given":"Guanghui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susann","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor S.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linnea","family":"S\u00e4r\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Sagemark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva Lamm","family":"Bergstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per","family":"\u00c5berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ollerstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorrit J.","family":"Hornberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H.","family":"Dockrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Betts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kinga Balogh","family":"Sivars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,6]]},"reference":[{"issue":"6","key":"3856_CR1","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1016\/j.anai.2023.02.010","volume":"130","author":"L Cannon","year":"2023","unstructured":"Cannon L, Pan A, Kovalick L, Sarkissian A, Wu EY. Secondary immunodeficiencies and infectious considerations of biologic immunomodulatory therapies. Annals allergy asthma immunology: official publication Am Coll Allergy Asthma Immunol. 2023;130(6):718\u201326.","journal-title":"Annals allergy asthma immunology: official publication Am Coll Allergy Asthma Immunol"},{"issue":"3","key":"3856_CR2","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1182\/blood-2016-02-702761","volume":"128","author":"CY Cheah","year":"2016","unstructured":"Cheah CY, Fowler NH. Idelalisib in the management of lymphoma. Blood. 2016;128(3):331\u20136.","journal-title":"Blood"},{"issue":"4","key":"3856_CR3","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1183\/13993003.01670-2015","volume":"47","author":"E Haustraete","year":"2016","unstructured":"Haustraete E, Obert J, Diab S, Abbes S, Zini JM, Valade S, Lerolle N, Albin N, Arnulf B, Bouaziz JD, Hussenet C, Tazi A, Bergeron A. Idelalisib-related pneumonitis. Eur Respir J. 2016;47(4):1280\u20133.","journal-title":"Eur Respir J"},{"key":"3856_CR4","doi-asserted-by":"crossref","unstructured":"Ward LM, Peluso MJ, Budak JZ, Elicker BM, Chin-Hong PV, Lampiris H, Mulliken JS. Opportunistic coinfection with Pneumocystis jirovecii and Coccidioides immitis associated with idelalisib treatment in a patient with chronic lymphocytic leukaemia. BMJ Case Rep. 2020;13(4):e234113.","DOI":"10.1136\/bcr-2019-234113"},{"issue":"8","key":"3856_CR5","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1136\/ard.2005.048371","volume":"65","author":"RM Fleischmann","year":"2006","unstructured":"Fleischmann RM, Tesser J, Schiff MH, Schechtman J, Burmester GR, Bennett R, Modafferi D, Zhou L, Bell D, Appleton B. Safety of extended treatment with anakinra in patients with rheumatoid arthritis. Ann Rheum Dis. 2006;65(8):1006\u201312.","journal-title":"Ann Rheum Dis"},{"key":"3856_CR6","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1186\/s13075-015-0880-2","volume":"17","author":"V Strand","year":"2015","unstructured":"Strand V, Ahadieh S, French J, Geier J, Krishnaswami S, Menon S, Checchio T, Tensfeldt TG, Hoffman E, Riese R, Boy M, G\u00f3mez-Reino JJ. Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials. Arthritis Res therapy. 2015;17:362.","journal-title":"Arthritis Res therapy"},{"issue":"1","key":"3856_CR7","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s12931-019-1131-x","volume":"20","author":"G Liu","year":"2019","unstructured":"Liu G, Betts C, Cunoosamy DM, \u00c5berg PM, Hornberg JJ, Sivars KB, Cohen TS. Use of precision cut lung slices as a translational model for the study of lung biology. Respir Res. 2019;20(1):162.","journal-title":"Respir Res"},{"key":"3856_CR8","doi-asserted-by":"crossref","unstructured":"Bauer CM, Zavitz CC, Botelho FM, Lambert KN, Brown EG, Mossman KL, Taylor JD, St\u00e4mpfli MR. Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection. PLoS ONE. 2010;5(10):e13251.","DOI":"10.1371\/journal.pone.0013251"},{"issue":"2","key":"3856_CR9","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1080\/21645515.2017.1264794","volume":"13","author":"A Temann","year":"2017","unstructured":"Temann A, Golovina T, Neuhaus V, Thompson C, Chichester JA, Braun A, Yusibov V. Evaluation of inflammatory and immune responses in long-term cultured human precision-cut lung slices. Hum vaccines immunotherapeutics. 2017;13(2):351\u20138.","journal-title":"Hum vaccines immunotherapeutics"},{"key":"3856_CR10","doi-asserted-by":"crossref","unstructured":"Donovan C, Seow HJ, Bourke JE, Vlahos R. Influenza A virus infection and cigarette smoke impair bronchodilator responsiveness to \u03b2-adrenoceptor agonists in mouse lung. Clin Sci (London, England: 1979). 2016;130(10):829\u201337.","DOI":"10.1042\/CS20160093"},{"key":"3856_CR11","doi-asserted-by":"crossref","unstructured":"Seehase S, Lauenstein HD, Schlumbohm C, Switalla S, Neuhaus V, F\u00f6rster C, Fieguth HG, Pfennig O, Fuchs E, Kaup FJ, Bleyer M, Hohlfeld JM, Braun A, Sewald K, Knauf S. LPS-induced lung inflammation in marmoset monkeys - an acute model for anti-inflammatory drug testing. PLoS ONE. 2012;7(8):e43709.","DOI":"10.1371\/journal.pone.0043709"},{"key":"3856_CR12","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12995-017-0158-5","volume":"12","author":"V Neuhaus","year":"2017","unstructured":"Neuhaus V, Schaudien D, Golovina T, Temann UA, Thompson C, Lippmann T, Bersch C, Pfennig O, Jonigk D, Braubach P, Fieguth HG, Warnecke G, Yusibov V, Sewald K, Braun A. Assessment of long-term cultivated human precision-cut lung slices as an ex vivo system for evaluation of chronic cytotoxicity and functionality. J Occup Med Toxicol (London England). 2017;12:13.","journal-title":"J Occup Med Toxicol (London England)"},{"issue":"5","key":"3856_CR13","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1165\/rcmb.2015-0290MA","volume":"54","author":"Y Bai","year":"2016","unstructured":"Bai Y, Krishnamoorthy N, Patel KR, Rosas I, Sanderson MJ, Ai X. Cryopreserved Human Precision-Cut Lung Slices as a Bioassay for Live Tissue Banking. A Viability Study of Bronchodilation with Bitter-Taste Receptor Agonists. Am J Respir Cell Mol Biol. 2016;54(5):656\u201363.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"3856_CR14","doi-asserted-by":"publisher","first-page":"2871","DOI":"10.1007\/s00204-021-03096-y","volume":"95","author":"G Liu","year":"2021","unstructured":"Liu G, S\u00e4r\u00e9n L, Douglasson H, Zhou XH, \u00c5berg PM, Ollerstam A, Betts CJ, Sivars B, K. Precision cut lung slices: an ex vivo model for assessing the impact of immunomodulatory therapeutics on lung immune responses. Arch Toxicol. 2021;95(8):2871\u20137.","journal-title":"Arch Toxicol"},{"issue":"7","key":"3856_CR15","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1164\/rccm.201608-1714OC","volume":"196","author":"MA Bewley","year":"2017","unstructured":"Bewley MA, Preston JA, Mohasin M, Marriott HM, Budd RC, Swales J, Collini P, Greaves DR, Craig RW, Brightling CE, Donnelly LE, Barnes PJ, Singh D, Shapiro SD, Whyte MKB, Dockrell DH. Impaired Mitochondrial Microbicidal Responses in Chronic Obstructive Pulmonary Disease Macrophages. Am J Respir Crit Care Med. 2017;196(7):845\u201355.","journal-title":"Am J Respir Crit Care Med"},{"key":"3856_CR16","doi-asserted-by":"crossref","unstructured":"Bewley MA, Naughton M, Preston J, Mitchell A, Holmes A, Marriott HM, Read RC, Mitchell TJ, Whyte MK, Dockrell DH. Pneumolysin activates macrophage lysosomal membrane permeabilization and executes apoptosis by distinct mechanisms without membrane pore formation. mBio. 2014;5(5).","DOI":"10.1128\/mBio.01710-14"},{"issue":"19","key":"3856_CR17","first-page":"3047","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, K\u00e4ller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinf (Oxford England). 2016;32(19):3047\u20138.","journal-title":"Bioinf (Oxford England)"},{"issue":"4","key":"3856_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.3317","volume":"12","author":"D Kim","year":"2015","unstructured":"Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357\u201360.","journal-title":"Nat Methods"},{"key":"3856_CR19","doi-asserted-by":"crossref","unstructured":"Liao Y, Smyth GK, Shi W. The R package Rsubread is easier, faster, cheaper and better for alignment and quantification of RNA sequencing reads. Nucleic Acids Res. 2019;47(8):e47.","DOI":"10.1093\/nar\/gkz114"},{"issue":"3","key":"3856_CR20","doi-asserted-by":"publisher","first-page":"lqaa078","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Parmigiani G, Johnson WE. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR genomics Bioinf. 2020;2(3):lqaa078.","journal-title":"NAR genomics Bioinf"},{"issue":"2","key":"3856_CR21","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1186\/gb-2014-15-2-r29","volume":"15","author":"CW Law","year":"2014","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29.","journal-title":"Genome Biol"},{"key":"3856_CR22","doi-asserted-by":"crossref","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","DOI":"10.1093\/nar\/gkv007"},{"issue":"4","key":"3856_CR23","first-page":"523","volume":"30","author":"A Kr\u00e4mer","year":"2014","unstructured":"Kr\u00e4mer A, Green J, Pollard J Jr, Tugendreich S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinf (Oxford England). 2014;30(4):523\u201330.","journal-title":"Bioinf (Oxford England)"},{"issue":"4","key":"3856_CR24","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1128\/JVI.01271-08","volume":"83","author":"K Goris","year":"2009","unstructured":"Goris K, Uhlenbruck S, Schwegmann-Wessels C, K\u00f6hl W, Niedorf F, Stern M, Hewicker-Trautwein M, Bals R, Taylor G, Braun A, Bicker G, Kietzmann M, Herrler G. Differential sensitivity of differentiated epithelial cells to respiratory viruses reveals different viral strategies of host infection. J Virol. 2009;83(4):1962\u20138.","journal-title":"J Virol"},{"issue":"6","key":"3856_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41579-018-0001-8","volume":"16","author":"JN Weiser","year":"2018","unstructured":"Weiser JN, Ferreira DM, Paton JC. Streptococcus pneumoniae: transmission, colonization and invasion. Nat Rev Microbiol. 2018;16(6):355\u201367.","journal-title":"Nat Rev Microbiol"},{"key":"3856_CR26","doi-asserted-by":"crossref","unstructured":"Parker D, Martin FJ, Soong G, Harfenist BS, Aguilar JL, Ratner AJ, Fitzgerald KA, Schindler C, Prince A. Streptococcus pneumoniae DNA initiates type I interferon signaling in the respiratory tract. mBio. 2011;2(3).","DOI":"10.1128\/mBio.00016-11"},{"key":"3856_CR27","doi-asserted-by":"publisher","first-page":"608625","DOI":"10.3389\/fimmu.2021.608625","volume":"12","author":"L Rohrbacher","year":"2021","unstructured":"Rohrbacher L, Brauchle B, Wagner O, von Bergwelt-Baildon A, B\u00fccklein M, V. L., Subklewe M. The PI3K\u2202-Selective Inhibitor Idelalisib Induces T- and NK-Cell Dysfunction Independently of B-Cell Malignancy-Associated Immunosuppression. Front Immunol. 2021;12:608625.","journal-title":"Front Immunol"},{"issue":"1","key":"3856_CR28","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41392-021-00687-0","volume":"6","author":"D Li","year":"2021","unstructured":"Li D, Wu M. Pattern recognition receptors in health and diseases. Signal Transduct Target therapy. 2021;6(1):291.","journal-title":"Signal Transduct Target therapy"},{"issue":"4","key":"3856_CR29","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1167\/iovs.07-1099","volume":"49","author":"L Wang","year":"2008","unstructured":"Wang L, Chen Y, Sternberg P, Cai J. Essential roles of the PI3 kinase\/Akt pathway in regulating Nrf2-dependent antioxidant functions in the RPE. Investig Ophthalmol Vis Sci. 2008;49(4):1671\u20138. (24).","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"9","key":"3856_CR30","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1084\/jem.186.9.1487","volume":"186","author":"D Cox","year":"1997","unstructured":"Cox D, Chang P, Zhang Q, Reddy PG, Bokoch GM, Greenberg S. Requirements for both Rac1 and Cdc42 in membrane ruffling and phagocytosis in leukocytes. J Exp Med. 1997;186(9):1487\u201394.","journal-title":"J Exp Med"},{"issue":"6","key":"3856_CR31","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/smim.2001.0331","volume":"13","author":"F Castellano","year":"2001","unstructured":"Castellano F, Chavrier P, Caron E. Actin dynamics during phagocytosis. Semin Immunol. 2001;13(6):347\u201355.","journal-title":"Semin Immunol"},{"issue":"2","key":"3856_CR32","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nri1268","volume":"4","author":"M Vicente-Manzanares","year":"2004","unstructured":"Vicente-Manzanares M, S\u00e1nchez-Madrid F. Role of the cytoskeleton during leukocyte responses. Nat Rev Immunol. 2004;4(2):110\u201322.","journal-title":"Nat Rev Immunol"},{"key":"3856_CR33","doi-asserted-by":"publisher","first-page":"8623","DOI":"10.1038\/ncomms9623","volume":"6","author":"D Schlam","year":"2015","unstructured":"Schlam D, Bagshaw RD, Freeman SA, Collins RF, Pawson T, Fairn GD, Grinstein S. Phosphoinositide 3-kinase enables phagocytosis of large particles by terminating actin assembly through Rac\/Cdc42 GTPase-activating proteins. Nat Commun. 2015;6:8623.","journal-title":"Nat Commun"},{"issue":"9","key":"3856_CR34","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nri3877","volume":"15","author":"S Mostowy","year":"2015","unstructured":"Mostowy S, Shenoy AR. The cytoskeleton in cell-autonomous immunity: structural determinants of host defence. Nat Rev Immunol. 2015;15(9):559\u201373.","journal-title":"Nat Rev Immunol"},{"issue":"18","key":"3856_CR35","doi-asserted-by":"publisher","first-page":"2921","DOI":"10.3390\/cells11182921","volume":"11","author":"JK Kim","year":"2022","unstructured":"Kim JK, Silwal P, Jo EK. Sirtuin 1 in Host Defense during Infection. Cells. 2022;11(18):2921.","journal-title":"Cells"},{"issue":"2","key":"3856_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3858\/emm.2012.44.2.032","volume":"44","author":"JM Yuk","year":"2012","unstructured":"Yuk JM, Yoshimori T, Jo EK. Autophagy and bacterial infectious diseases. Exp Mol Med. 2012;44(2):99\u2013108.","journal-title":"Exp Mol Med"},{"issue":"7241","key":"3856_CR37","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/nature07813","volume":"458","author":"C Cant\u00f3","year":"2009","unstructured":"Cant\u00f3 C, Gerhart-Hines Z, Feige JN, Lagouge M, Noriega L, Milne JC, Elliott PJ, Puigserver P, Auwerx J. AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity. Nature. 2009;458(7241):1056\u201360.","journal-title":"Nature"},{"key":"3856_CR38","doi-asserted-by":"crossref","unstructured":"Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Sinclair DA. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab. 2012;15(5):675\u201390.","DOI":"10.1016\/j.cmet.2012.04.003"},{"issue":"4","key":"3856_CR39","doi-asserted-by":"publisher","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","volume":"298","author":"NB Ruderman","year":"2010","unstructured":"Ruderman NB, Xu XJ, Nelson L, Cacicedo JM, Saha AK, Lan F, Ido Y. AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab. 2010;298(4):E751\u201360.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"47","key":"3856_CR40","doi-asserted-by":"publisher","first-page":"28425","DOI":"10.1074\/jbc.270.47.28425","volume":"270","author":"SH Hansen","year":"1995","unstructured":"Hansen SH, Olsson A, Casanova JE. Wortmannin, an inhibitor of phosphoinositide 3-kinase, inhibits transcytosis in polarized epithelial cells. J Biol Chem. 1995;270(47):28425\u201332.","journal-title":"J Biol Chem"},{"key":"3856_CR41","doi-asserted-by":"crossref","unstructured":"Duncia JV, Santella JB 3rd, Higley CA, Pitts WJ, Wityak J, Frietze WE, Rankin FW, Sun JH, Earl RA, Tabaka AC, Teleha CA, Blom KF, Favata MF, Manos EJ, Daulerio AJ, Stradley DA, Horiuchi K, Copeland RA, Scherle PA, Trzaskos JM, Olson RE. MEK inhibitors:the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg Med Chem Lett. 1998;8(20):2839\u201344.","DOI":"10.1016\/S0960-894X(98)00522-8"},{"issue":"2","key":"3856_CR42","doi-asserted-by":"publisher","first-page":"109","DOI":"10.4161\/cbt.9.2.10583","volume":"9","author":"SY Sun","year":"2010","unstructured":"Sun SY. N-acetylcysteine, reactive oxygen species and beyond. Cancer Biol Ther. 2010;9(2):109\u201310.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"3856_CR43","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1161\/CIRCRESAHA.109.214601","volume":"107","author":"AE Dikalova","year":"2010","unstructured":"Dikalova AE, Bikineyeva AT, Budzyn K, Nazarewicz RR, McCann L, Lewis W, Harrison DG, Dikalov SI. Therapeutic targeting of mitochondrial superoxide in hypertension. Circul Res. 2010;107(1):106\u201316.","journal-title":"Circul Res"},{"issue":"8","key":"3856_CR44","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1080\/15548627.2015.1066957","volume":"11","author":"C Mauvezin","year":"2015","unstructured":"Mauvezin C, Neufeld TP. Bafilomycin A1 disrupts autophagic flux by inhibiting both V-ATPase-dependent acidification and Ca-P60A\/SERCA-dependent autophagosome-lysosome fusion. Autophagy. 2015;11(8):1437\u20138.","journal-title":"Autophagy"},{"issue":"8","key":"3856_CR45","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/15548627.2018.1474314","volume":"14","author":"M Mauthe","year":"2018","unstructured":"Mauthe M, Orhon I, Rocchi C, Zhou X, Luhr M, Hijlkema KJ, Coppes RP, Engedal N, Mari M, Reggiori F. Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8):1435\u201355.","journal-title":"Autophagy"},{"issue":"3","key":"3856_CR46","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1128\/IAI.66.3.912-922.1998","volume":"66","author":"Y Bergeron","year":"1998","unstructured":"Bergeron Y, Ouellet N, Deslauriers AM, Simard M, Olivier M, Bergeron MG. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice. Infect Immun. 1998;66(3):912\u201322.","journal-title":"Infect Immun"},{"issue":"1","key":"3856_CR47","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1111\/imr.13067","volume":"307","author":"J Bier","year":"2022","unstructured":"Bier J, Deenick EK. The role of dysregulated PI3Kdelta signaling in human autoimmunity. Immunol Rev. 2022;307(1):134\u201344.","journal-title":"Immunol Rev"},{"key":"3856_CR48","doi-asserted-by":"crossref","unstructured":"Angulo I, Vadas O, Gar\u00e7on F, Banham-Hall E, Plagnol V, Leahy TR, Baxendale H, Coulter T, Curtis J, Wu C, Blake-Palmer K, Perisic O, Smyth D, Maes M, Fiddler C, Juss J, Cilliers D, Markelj G, Chandra A, Farmer G, Nejentsev S. Phosphoinositide 3-kinase \u03b4 gene mutation predisposes to respiratory infection and airway damage. Science (New York, N.Y.). 2013;342(6160):866\u201371.","DOI":"10.1126\/science.1243292"},{"issue":"2","key":"3856_CR49","doi-asserted-by":"publisher","first-page":"265","DOI":"10.3892\/mmr.2022.12781","volume":"26","author":"J Kuai","year":"2022","unstructured":"Kuai J, Zhang N. Upregulation of SIRT1 by Evodiamine activates PI3K\/AKT pathway and blocks intervertebral disc degeneration. Mol Med Rep. 2022;26(2):265.","journal-title":"Mol Med Rep"},{"key":"3856_CR50","doi-asserted-by":"crossref","unstructured":"Opal SM, Ellis JL, Suri V, Freudenberg JM, Vlasuk GP, Li Y, Chahin AB, Palardy JE, Parejo N, Yamamoto M, Chahin A, Kessimian N. Pharmacological sirt1 activation improves mortality and markedly alters transcriptional profiles that accompany experimental sepsis. Shock (Augusta, Ga.). 2016;45(4):411\u20138.","DOI":"10.1097\/SHK.0000000000000528"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-026-03856-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03856-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-026-03856-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T02:27:58Z","timestamp":1785983278000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12931-026-03856-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,6]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3856"],"URL":"https:\/\/doi.org\/10.1186\/s12931-026-03856-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,6]]},"assertion":[{"value":"2 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Susann Busch, Taylor S. Cohen, Linnea S\u00e4r\u00e9n, Johanna Sagemark, Eva Lamm Bergstr\u00f6m, Xiao-Hong Zhou, Per \u00c5berg, Anna Ollerstam, Jorrit J. Hornberg, Catherine J. Betts and Kinga Balogh Sivars are employed by AstraZeneca plc and may be shareholders.","order":2,"name":"Ethics","label":"Competing insterests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"301"}}